Benzamide

Research use only, not for human use.

Benzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic acid.

Benzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic acid.

——

Benzamide (160 mg/kg; IP, 2 injection by a 4 h interval) attenuates the METH-induced dopamine depletions.Benzamide (160 mg/kg; IP, single dosage) has no acute effect on striatal dopamine metabolism and does not reduce body temperature. Animal Model:C57B1/6N mice (intraperitoneal injection of METH at 2-h intervals; 4 injections of 5 mg/kg, 4 injections of 10 mg/kg, or 2 injections of 20 mg/kg) Dosage:160 mg/kg Administration:IP, 2 injection by a 4 h interval Result:Partially and significantly attenuated the METH-induced dopamine depletions during the different METH treatment.Animal Model:C57B1/6N mice Dosage:160 mg/kg Administration:IP, single dosage Result:Had no acute effect on striatal dopamine metabolism and did not reduce body temperature.

——

Others

Other Targets

PARP

Neurological Disease

——

55-21-0

121.14

C7H7NO

>98% (HPLC)

In Vitro:?DMSO : 120 mg/mL (990.59 mM)

C1=CC=C(C=C1)C(=O)N

——

(-20℃)

With Ice Pack

≥ 2 years